Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties. (1/5)

Unusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans. (2/5)

Characterization of the complete uric acid degradation pathway in the fungal pathogen Cryptococcus neoformans. (3/5)

Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis. (4/5)

Nitrogen source-dependent capsule induction in human-pathogenic cryptococcus species. (5/5)